359. Fibrin-Conjugated Pseudotyped Lentivirus for Cell-Controlled and Spatially Localized Gene Delivery on Microarrayed Surfaces

359. Fibrin-Conjugated Pseudotyped Lentivirus for Cell-Controlled and Spatially Localized Gene Delivery on Microarrayed Surfaces

RNA VIRUS VECTORS I 357. ‘Self’ Marker CD47 on Viral Envelopes Nisha Sosale,1 Richard K. Tsai,1 Irena Ivanovska,1 Philip W. Zoltick,2 Dennis E. Disc...

382KB Sizes 1 Downloads 29 Views

RNA VIRUS VECTORS I 357.

‘Self’ Marker CD47 on Viral Envelopes

Nisha Sosale,1 Richard K. Tsai,1 Irena Ivanovska,1 Philip W. Zoltick,2 Dennis E. Discher.1 1 Biophysical Engineering Lab, University of Pennsylvania, Philadelphia, PA; 2Department of Surgery, The Children’s Hospital of Philadelphia, Philadelphia, PA. Viruses that bud from the plasma membrane of host cells are enveloped by host cell membrane lipids and - probably - proteins as well. Among these proteins is CD47, which is a ubiquitous ‘Marker of Self’ that can in principle decrease particle clearance (and destruction) by the monocytic phagocyte system. To examine whether viral presentation of CD47 reduces phagocytosis by macrophages, CD47 was displayed at high levels on HIV 1 derived lentiviral vectors. The human-derived 293T packaging cell line was transduced and a stable line created that expressed CD47-GFP, and then these cells were transfected to produce the lentiviral vectors. We use sucrose ultracentrifugation gradient to separate lentiviruses from cell debris. Preliminary data suggests viral display of CD47 by single particle GFP uorescence. Transduction studies of macrophages - which express the counter receptor for CD47 - and other cell types are ongoing, but we expect decreased transduction only of macrophages. Additional motivation for the effort is based on the fact that immune responses to gene therapy vectors and their transgene products is a major problem in the eld of gene therapy. Understanding whether ‘Self’ Marker CD47 on viral envelopes decreases immune uptake is thus of both basic and applied signicance.

358. Lentiviral Microarrays for High-Throughput and Real-Time Monitoring of Gene Expression Dynamics Jun Tian,1 Stella Allimperti,1 Pedro Lei,1 Stelios T. Andreadis.1 Chemical and Biological Engineering, State University of New York at Buffalo, Amherst, NY.

1

Quantication of gene expression dynamics is limited due to the destructive, expensive and laborious nature of current gene expression proling techniques such as qRT-PCR and cDNA microarrays. Here we developed scalable live-cell microarrays to measure gene expression dynamics in real-time and in a high-throughput manner. To this end, we generated dual-promoter lentiviral vectors that were designed to eliminate promoter interference and provide independent and high level gene expression from two gene cassettes. Each lentivirus harbored a transcriptional regulatory element encoding for destabilized green uorescence protein to monitor cell activation in response to an exogenous signal and a constitutive promoter driving red uorescence protein for internal signal normalization. Lentivirus preparations were immobilized in a microarray format using a robotic spotter to generate the LentiVirus microArray (LVA). Target cells were transduced with immobilized lentivirus and after cytokine treatment transcriptional activity was interrogated in real-time using automated uorescence microscopy. In contrast to standard methods, our experiments provided rich dynamic information over a period of several days. Data normalization by red uorescence intensity eliminated errors due to spot-to-spot variability in transduction efciency or changes in cell proliferation upon cytokine treatment. These results were conrmed by ow cytometry and qRT-PCR and demonstrated that the LVA can monitor gene expression in realtime and high-throughput manner thereby providing a useful tool for deciphering gene regulatory networks of complex biological processes such as inammatory response or stem cell differentiation.

Molecular Therapy Volume 18, Supplement 1, May 2010 Copyright © The American Society of Gene & Cell Therapy

359. Fibrin-Conjugated Pseudotyped Lentivirus for Cell-Controlled and Spatially Localized Gene Delivery on Microarrayed Surfaces Roshan Padmashali, Pedro Lei, Stelios Andreadis. Chemical and Biological Engineering, State University of New York at Buffalo, Amherst, NY.

Recently, we reported that brin hydrogels can be used for effective pDNA encapsulation and gene delivery. Here we report our recent efforts to immobilize lentivirus in brin gels to achieve gene transfer in a cell-controlled and spatially arranged manner. Transduction efciency on brin gels was comparable to conventional methods but cellular toxicity was signicantly diminished. Gene transfer was strongly dependent on matrix degradation by target cells but a signicant fraction of lentiviral particles diffused out of the gel over time. To eliminate viral diffusion we engineered lentiviral particles that bind covalently to brin during polymerization. To this end, we engineered fusion proteins between the viral envelope glycoprotein (VSV-G), peptide domains that are recognized by factor XIII and protease cleavage sites that are recognized by plasmin. All modied variants exhibited similar transduction efciency with the wild type and bound to brin hydrogels in a factor XIII dose dependent manner. As a result diffusion of virus from the gels decreased dramatically even for brin gels with low brinogen concentration. When the modied lentivirus preparations were spotted in an array format, gene transfer was strictly conned to virus-containing brin spots with no cross-contamination between neighboring sites suggesting that this transduction system may be ideal for generation of lentiviral microarrays for high throughput studies.

360. Improved Transduction Efciency of Human Amniotic Mesenchymal Stem Cells Using Optimized Lentiviral Vectors

F. Pisano,1 P. Danieli,1 E. Cervio,1 C. Ciuffreda,1 M. Roccio,1 G. Viarengo,1 M. Gnecchi.1 1 Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Background: Amniotic mesenchymal stem cells (A-MSC) are excellent candidates for regenerative medicine since they are multipotent, easy to isolate, expandable and seem to be immunoprivileged. In rodents, stable genetic modication with viral vectors improves A-MSC function. Unfortunately, a single cycle transduction with standard viral vectors does not achieve high efciency in human A-MSC. On the other hand, multiple transduction cycles or antibiotic-based selection methods may alter S139